Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ovid Therapeutics Inc (NQ: OVID ) 1.220 -0.020 (-1.61%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ovid Therapeutics Inc < Previous 1 2 3 4 Next > Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat June 17, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire 3 Sorry Penny Stocks to Sell in May While You Still Can May 28, 2024 Steer clear of these three penny stocks to sell that are plagued by financial instability and mounting losses. Via InvestorPlace Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 May 20, 2024 Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. Via InvestorPlace OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 OVID stock results show that Ovid Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results May 14, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics May 07, 2024 Via Benzinga Recap: Ovid Therapeutics Q4 Earnings March 08, 2024 Via Benzinga Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference May 13, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 24, 2024 Via Benzinga Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying March 21, 2024 The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Ovid Therapeutics Earnings Perspective: Return On Capital Employed May 22, 2023 Via Benzinga Ovid Therapeutics: Q1 Earnings Insights May 05, 2023 Via Benzinga Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results March 08, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference February 28, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023) December 01, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates November 03, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026 October 18, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit October 10, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023 September 26, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference September 20, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Participate in Upcoming September Investor Conferences August 30, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire 3 Very Promising Penny Stocks That Are Flying Under the Radar August 15, 2023 Although the very concept of penny stocks to buy screams risk, these ideas just might be intriguing enough for speculators. Via InvestorPlace Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates August 04, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023 August 01, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer June 28, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Added to Russell 3000® Index June 26, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates May 05, 2023 From Ovid Therapeutics Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 June 14, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
